Industry news focusing on the people and organizations who work in the clinical trials profession.
Medical Research Network (Buckinghamshire, UK) announced the hire of three more healthcare professionals. Sheetal Kumar joined as a Research Nurse Manager; Laurie James joined as a Project Manager; and Helen Marks, PhD, joined the Vendor & Contracts Management Team.
Packaging Coordinators, Inc. (PCI) (Philadelphia, PA) announced the addition of Tim Brown to its Global Clinical Services staff, assuming the role of Director of Project Management for North American Operations.
Biotec Services International (Bridgend, UK) announced the appointment of Ashley Cooper—Founder and Chief Executive Officer of TES Aviation Group—to its Board of Directors.
Celerion (Lincoln, NE) announced the expansion of a formal business presence in Singapore. Heading up the new operations in Singapore is Chew Lan Chong, MBBS, MCRS, MSc, as Executive Director, Medical Research.
Certara (St. Louis, MO) announced Edmundo Muniz, MD, PhD, MS, has been appointed its new Chief Executive Officer.
CSSi (Glen Burnie, MD) announced the formation of the company’s Medical and Clinical Advisory Board, and the appointment of Ronald M. Bukowski, MD, as its chairman.
CTI Clinical Trial and Consulting Services (Cincinnati, OH) announced Joseph M. McCafferty has been promoted to Vice President, Sales North America, leading the sales team as it continues to grow and expand to geographies across the globe.
Clinipace Worldwide (Morrisville, NC) announced the addition of Roger Morgan, MD, FACS, as Executive Vice President, Global Medical Affairs.
Pharmaceutical Product Development (PPD) (Wilmington, NC) announced that it has been selected as one of the most innovative organizations using information technology to create business value by CIO magazine’s 27th annual CIO 100 Awards.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.